Comparison of percutaneous coronary intervention versus medication in dialysis patients with coronary artery disease

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Enmin Xie

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

4 More presentations in this session

Presentation thumbnail

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events.

Doctor S. Ikebe (Kumamoto, JP)

Abstract Slides Video

Presentation thumbnail

High bleeding risk mainly predicts non-access site bleeding events in the first month after percutaneous coronary intervention

Ms E. Woelders (Nijmegen, NL)

Abstract Slides Video

Presentation thumbnail

Parsimonious versus extensive score: can we simplify bleeding risk stratification after percutaneous coronary intervention without losing specificity?

Ms E. Woelders (Nijmegen, NL)

Abstract Slides Video

Presentation thumbnail

Platelet reactivity and activated clotting time predict haemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary intervention

Doctor B. Ramotowski (Warsaw, PL)

Abstract Slides Video

Access the full session

Session thumbnail

Renal failure and bleeding in PCI patients

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Presentation

Percutaneous intervention is better than surgery in real life for most patients: pro

Congress Presentation

Association of PCI with outcomes in stable coronary artery disease

Congress Presentation

Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources